Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Safety and Tolerability
- Interventions
- Drug: YJ001 for Spray UseDrug: Placebo of YJ001 for Spray Use
- First Posted Date
- 2022-07-11
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Yuejia Pharmaceuticals (USA), Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05451667
- Locations
- 🇺🇸
Pharmaron CPC, Inc., Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath